Global Dermatologicals Market Statistics, Development and Growth 2021
Dermatologicals is set to record higher value growth, with 6% value growth predicted against 4% recorded in 2019. Demand for topical germicidals/antiseptics was boosted in Q1 and Q2 by the outbreak of COVID-19, with consumers stockpiling behaviour leading to a predicted double-digit increase in value growth for the products.
Euromonitor International's Dermatologicals in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor
International has over 40 years' experience of publishing market research
reports, business reference books and online information systems. With offices
in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago,
Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide,
Euromonitor International has a unique capability to develop reliable
information resources to help drive informed strategic planning.
Table ofContent
KEY DATA FINDINGS
2020 IMPACT
Frequent handwashing and use of home
disinfectants causes skin issues for some consumers, boosting growth for
dermatologicals
Antiparasitics/lice (head and body) treatments
record a value decline as the closure of schools reduces the spread of lice
Well-known brands retain the trust of
consumers, with a lack of private label offerings within dermatologicals
RECOVERY AND OPPORTUNITIES
Following a spike in growth due to COVID-19,
lower levels to be recorded in 2021; however, positive growth is driven by
antipruritics
Pollution, climate change and an ageing
population will remain key growth drivers across the forecast period
Growing awareness of the effectiveness of
antipruritics boosts demand across the forecast period, as the product drives
the highest value growth
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category:
Value 2015-2020
Table 2 Sales of Dermatologicals by Category: %
Value Growth 2015-2020
Table 3 NBO Company Shares of Dermatologicals:
% Value 2016-2020
Table 4 LBN Brand Shares of Dermatologicals: %
Value 2017-2020
Table 5 LBN Brand Shares of Hair Loss
Treatments: % Value 2017-2020
Table 6 Forecast Sales of Dermatologicals by
Category: Value 2020-2025
Table 7 Forecast Sales of Dermatologicals by
Category: % Value Growth 2020-2025
EXECUTIVE SUMMARY
COVID-19 impact on consumer health
…... continued
CONTACT
DETAILS :
+44 203 500 2763
+1 62 825 80070
971 0503084105
Comments
Post a Comment